On the other hand, increased levels of survivin have been found in gastric, esophageal, ovarian cancer, and NSCLC patients [41]; deregulation of survivin expression in various cancer types leads to increased cisplatin-resistance in patients and is associated with a negative prognosis [42]. The gene discussed is BIRC5; the disease is cancer.